Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs061220039
JPRN-jRCTs061220039
Recruiting
未知

Efficucy and safty of transcatheter arterial micro-embolization for chronic post surgical pain after total knee arthroplasty

Sugimura Natsuki0 sites20 target enrollmentJuly 6, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionstotal knee arthroplasty/ chronic post-surgical painCronic post-surgical pain after total knee arthroplasty

Overview

Phase
未知
Intervention
Not specified
Conditions
total knee arthroplasty/ chronic post-surgical pain
Sponsor
Sugimura Natsuki
Enrollment
20
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 6, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sugimura Natsuki

Eligibility Criteria

Inclusion Criteria

  • •Patients who meet all of the following criteria will be eligible.
  • •(1\) Patients who have undergone total knee arthroplasty (TKA) for osteoarthritis (OA) for at least one year at the time of consent.
  • •(2\) Patients with a pain VAS of 30 or higher at the time of consent.
  • •(3\) Patients whose age at the time of consent acquisition is between 50 and 90 years old.
  • •(4\) Patients with poor improvement after conservative therapy (NSAID patch, education, exercise therapy) for at least 3 months prior to obtaining consent (pain VAS 30 or higher).

Exclusion Criteria

  • •Patients who meet at least one of the following criteria will be excluded from the study. Patients who meet any one of the following criteria will not be allowed to participate in this study.
  • •(1\) Patients with active indications for surgical treatment (e.g. aseptic loosening)
  • •(2\) Patients with any of the following conditions: infection, rheumatoid arthritis, or mental illness.
  • •(3\) Patients with poor alignment
  • •(4\) Patients with actively suspected pain due to spinal lesions
  • •(5\) Patients with a high psychogenic predisposition to pain
  • •(6\) Patients with poorly controlled diabetesmellitus
  • •(7\) Patients taking antithrombotic medication which can not be suspended
  • •(8\) Patients with severely impaired renal function
  • •(9\) Patients with bronchial asthma

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Safety and efficacy of transcatheter arterial micro-embolization for postherpetic neuralgia resistant to conservative treatment
JPRN-UMIN000025018Edogawa Hospital33
Completed
Not Applicable
Safety and efficacy of transcatheter arterial micro embolization (TAME) using Imipenem / Cilastatin (IPM/CS) for chronic musculoskeletal pain refractory to non-surgical management.Musculoskeletal chronic pain refractory to non-surgical management(Glenohumeral joint, elbow joint, hip joint and knee joint)
JPRN-UMIN000026094Tottori university, Faculty of medicine20
Recruiting
Phase 1
Effectiveness of Transcatheter arterial micro-emblization for nighttime shoulder painighttime shoulder pain refractory to traditional managements
JPRN-UMIN000017524Edogawa musculoskeletal intervention study group50
Completed
Phase 2
Effectiveness of Transcatheter arterial micro-emblization for nighttime shoulder pain : Multicenter Studynighttime shoulder pain refractory to non-surgical management
JPRN-UMIN000021238Edogawa Hospital100
Recruiting
Phase 1
Safety and Effectiveness of transcatheter arterial micro-embolization as a treatment for ulnar collateral ligament injuries in baseball players refractory to conservative treatment
JPRN-UMIN000025017Edogawa Hospital33